Fig. 1 | Scientific Reports

Fig. 1

From: N7-methyladenosine-induced SLC7A7 serves as a prognostic biomarker in pan-cancer and promotes CRC progression in colorectal cancer

Fig. 1

Diagnostic and prognostic values of SLC7A7 expression in pan-cancer. (A) The mRNA expression levels of SLC7A7 among 31 different human cancer tissues. (B) Kaplan–Meier survival analysis indicated that the OS and DFS of patients with high expression of SLC7A7 were all shorter than those of patients with low expression. (C) SLC7A7 expression in colon cancer tissues was analyzed by GEO and TCGA databases (GSE21510, GSE71187, GSE87211, and TCGA). (D) SLC7A7 expression was analyzed by GSE106584 concerning OS and RFS. (E) Survival maps show the prognosis of different tumors. (F). Enrichment of GSEA results based on SLC7A7 expression of the KEGG and Hallmark pathway.

Back to article page